INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
110 hedge funds and large institutions have $84M invested in Insys Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 37 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
51% less capital invested
Capital invested by funds: $170M → $84M (-$86.3M)
Holders
110
Holding in Top 10
–
Calls
$3.29M
Puts
$3.82M
Top Buyers
| 1 | +$2.19M | |
| 2 | +$700K | |
| 3 | +$579K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$460K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$417K |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$11.4M | |
| 3 | -$4.18M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.21M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$888K |